HEALTHNEWS Merk and Ridgeback Biotherapeutics’ Oral Antiviral to Treat Covid-19 Authorized in United Kingdom by InlandTown Editor November 4, 2021 November 4, 2021 On Thursday, the UK Medicines and Healthcare Products Regulatory Agency said Merk and Ridgeback Biotherapeutics’ oral antiviral, molnupiravir, for the treatment of mild-to-moderate Covid-19… 2 FacebookTwitterPinterestWhatsappEmail
